Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide

NCT00609011 is registered in ClinicalTrials.gov with Myrexis Inc. as lead sponsor.

NCT NCT00609011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00609011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide
Lead sponsor
Myrexis Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2009
Enrollment
22 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma